Condition: Agitation · Sponsor: Teikoku Pharma USA, Inc.
The primary objective of this study is to evaluate the efficacy of DMTS on frequency and severity of agitation associated with dementia of the Alzheimer's type, compared with placebo.
This description comes directly from the study's public registry record.
Tami Ujiie · 408-501-1822 · tujiie@teikokuusa.com
Always discuss trial participation with your own doctor first.
| Arrow Clinical Trials | Daytona Beach, Florida, United States | Recruiting |
| Personal Physician Care | Delray Beach, Florida, United States | Recruiting |
| Global Medical Institutes Florida LLC | Miami, Florida, United States | Recruiting |
| Miami Jewish Health | Miami, Florida, United States | Recruiting |
| Professional Health Care of Pinellas, LLC | St. Petersburg, Florida, United States | Recruiting |
| Elixia MA, LLC | Springfield, Massachusetts, United States | Withdrawn |
| Vitalix | Worcester, Massachusetts, United States | Recruiting |
| BioBehavioral Health | Toms River, New Jersey, United States | Withdrawn |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06052254